← Back to news
Y

Yahoo Finance

Madison Mid Cap Fund Bets on Bentley Systems (BSY) for Years of Growth Ahead

Y

Equinor to transfer Peon interest to Vår Energi in NCS deal

Y

Palantir stock has crashed this year, but there may be upside ahead

Y

Do You Believe in the Long-Term Earnings Potential of Formula One Group (FWONK)?

Y

Does Tyler Technologies (TYL) Have a Long Runway for Sales Growth?

Y

NVIDIA (NVDA), Palantir (PLTR) Partner to Deploy Secure AI Models for Government and Infrastructure

Y

Palantir (PLTR), Surf Air Mobility Expand Partnership to Accelerate SurfOS Platform Development

Y

Adobe (ADBE) Launches Firefly Foundry to Enable Enterprise Custom AI Model Development

Y

CoreWeave (CRWV) Expands European AI Infrastructure Through New Partnership with Conapto

Y

International Business Machines (IBM) Unveils World’s First 0.7-Nanometer Semiconductor Tech

Y

Is Baidu (BIDU) One of the AI Stocks on Wall Street’s Radar?

Y

Digital Realty (DLR) Launches ServiceFabric MCP for AI-Native Infrastructure Control

Y

Here is Why SentinelOne (S) is One of the AI Stocks on Wall Street’s Radar

Y

Check Point (CHKP) Integrates OpenAI Frontier Models into Security Suite

Y

Cerebras Systems (CBRS): 10 AI Stocks on Wall Street’s Radar

Y

Is ServiceTitan (TTAN) Unfairly Punished Beyond Fundamentals?

Y

Italy’s La Doria buys B2B tomato supplier Solana

Y

Brown & Brown (BRO) Dropped on Softness in Organic Growth

Y

The John Rogers Contrarian Playbook: How Envista, MSG Entertainment, and Smucker Stack Up for Retirement Investors

Y

Where Will Tesla Stock Be in 5 Years?

Y

Is MapLight Therapeutics, Inc. (MPLT) Stock a Biotech Opportunity Ahead of the ZEPHYR Trial Readout?

Y

Is Rhythm Pharmaceuticals, Inc. (RYTM) Stock Poised for Growth After Encouraging Setmelanotide Trial Results?

Y

MoonLake Immunotherapeutics (MLTX) Outlook Strengthens as Analysts See Major Opportunity in Hidradenitis Suppurativa

Y

Is Definium Therapeutics, Inc. (DFTX) Stock Poised for Further Gains After Positive Emerge Trial Update?

Y

Is Zymeworks Inc. (ZYME) Stock an Undervalued Biotech Opportunity With Oncology Growth Ahead?

Y

Is Celldex Therapeutics, Inc. (CLDX) Stock Positioned for Growth Ahead of Potential 2027 Approval?

Y

Nurix Therapeutics, Inc. (NRIX) Price Target Raised to $33 on Roche Partnership Value

Y

Is Jade Biosciences, Inc. (JBIO) Stock a Rising Biotech Opportunity in the $20B IgA Nephropathy Market?

Y

Why Ascentage Pharma Group Internat (AAPG) Is Gaining Attention in Cancer Drug Development

Y

Is Medicus Pharma Ltd. (MDCX) Stock Gaining Momentum With Innovative Skin Cancer Treatment Technology?

Y

Is High Tide Inc. (HITI) Stock Turning Into a Cannabis Growth Story After Record Quarterly Results?

Y

Why Pfizer Could Prove to Be an Underrated GLP-1 Stock

Y

Meet the ETF That Beat the S&P 500 for Over 20 Years -- and History Suggests It's Ready to Pop Again

Y

Why Split With Waymo In Phoenix Could 'Weigh On' Uber Stock

Y

Drinks companies hit out at Germany’s sugar tax plans

Y

Disney $50M antitrust settlement: how to file a claim

Y

EchoStar prepares Dish DBS bankruptcy filing

Y

Maintenance staffing remains multifamily’s biggest labor challenge

Y

Teledyne Technologies (TDY) Reported Robust Organic Growth in Q1

Y

Why The Secret CFO calls this finance leader ‘the most AI-pilled CFO’

Y

Cooke nets Mowi salmon farms in Canada

Y

Can Lifecore Biomedical, Inc. (LFCR) Unlock Long-Term Value Through Expanding Biopharma Collaborations?

Y

Is Takeda Pharmaceutical Company Limited (TAK) Stock Positioned for Growth After Strong LATITUDE Atlas Study Data?

Y

Akebia Therapeutics, Inc. (AKBA) Strengthens Vafseo Patent Protection Through 2036

Y

GSK plc (GSK) Launches Tender Offer to Acquire Nuvalent Inc. for $124 Per Share

Y

3 Dividend Stocks Worth Buying More of While the Market Is Distracted

Y

Is Amylyx Pharmaceuticals, Inc. (AMLX) Stock Ready for a Breakout Ahead of Key LUCIDITY Trial Data?

Y

Microsoft Heads for Biggest Monthly Loss Since Dot-Com Burst

Y

Is BioAge Labs, Inc. (BIOA) Stock Positioned for Growth With New Phase 2 Cardiovascular Study Initiation?

Y

Comcast's NBCU split makes Wall Street's math easier

Y